May 30
|
3 Volatile Stocks in Hot Water
|
May 28
|
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
|
May 28
|
Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way
|
May 23
|
NeoGenomics introduces c-MET companion diagnostic for NSCLC
|
May 22
|
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
|
May 21
|
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
|
May 9
|
Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares
|
Mar 14
|
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
|
Mar 12
|
3 Small-Cap Stocks in Hot Water
|
Mar 10
|
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
|
Feb 24
|
NeoGenomics to Participate in Upcoming Investor Conferences
|
Feb 19
|
NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations
|
Feb 19
|
NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
Feb 19
|
Q4 2024 Neogenomics Inc Earnings Call
|
Feb 18
|
Why NeoGenomics (NEO) Shares Are Trading Lower Today
|
Feb 18
|
NeoGenomics (NEO) Tops Q4 Earnings Estimates
|
Feb 18
|
NeoGenomics: Q4 Earnings Snapshot
|
Feb 18
|
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
|
Feb 18
|
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
|
Feb 17
|
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
|